Mainz Biomed N.V. (QUCY)
NASDAQ: QUCY · Real-Time Price · USD
0.4751
+0.0170 (3.71%)
Apr 6, 2026, 4:00 PM EDT - Market closed

Mainz Biomed Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.896.247.0717.148.73
Cash & Short-Term Investments
0.896.247.0717.148.73
Cash Growth
-85.74%-11.81%-58.75%96.41%7020.57%
Accounts Receivable
0.080.050.090.070.11
Inventory
0.220.370.610.18-
Other Current Assets
0.661.361.20.990.77
Total Current Assets
1.848.028.9818.389.61
Net Property, Plant & Equipment
2.372.463.031.840.43
Other Intangible Assets
1.113.023.39--
Other Long-Term Assets
---0.02-
Total Assets
5.3313.515.4120.2410.04
Accounts Payable
0.952.933.482.720.87
Accrued Expenses
----0.23
Short-Term Debt
1.141.2--0.12
Current Portion of Long-Term Debt
0.081.094.941.040.08
Current Portion of Leases
0.360.260.290.290.06
Unearned Revenue
--0.140.2-
Other Current Liabilities
1.160.690.39--
Total Current Liabilities
3.696.189.244.241.35
Long-Term Debt
--1.030.941.94
Long-Term Leases
0.990.951.170.960.39
Other Long-Term Liabilities
-0.380.73--
Total Long-Term Liabilities
0.991.322.921.92.33
Total Liabilities
4.697.512.166.143.68
Common Stock
0.110.020.240.160.14
Additional Paid-in Capital
106.0595.2272.7956.9122.86
Accumulated Other Comprehensive Income
-0.62-0.55-0.450.050
Retained Earnings
-104.9-88.69-69.33-43.03-16.64
Shareholders' Equity
0.6463.2514.16.36
Total Liabilities & Equity
5.3313.515.4120.2410.04
Total Debt
2.573.57.423.232.58
Net Cash (Debt)
-1.682.73-0.3513.916.15
Net Cash Growth
---126.19%-
Net Cash Per Share
-0.282.77-0.8639.3134.12
Book Value
0.6463.2514.16.36
Book Value Per Share
0.116.088.0039.8335.29
Tangible Book Value
-0.472.98-0.1514.16.36
Tangible Book Value Per Share
-0.083.02-0.3639.8335.29
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q